A COVID-19 Outlook: Progress on antiviral drugs and vaccine development - Livestream

Bringing a new drug to market is a complex process with innumerable possible twists and turns. With a huge global research effort focused on SARS-CoV-2, the novel coronavirus causing COVID-19, what does that mean for the development of antiviral drugs and vaccines? What kind of jobs are in COVID-related research?

If you’re interested in learning more about the journey of drug discovery and the diverse job opportunities for newcomers to the field, please join Edward Rozhon, Ph.D., in a discussion about what’s involved in obtaining FDA approval to market antiviral drugs and vaccines - the scientific challenges, controversies, and socio-political and ethical issues.

Register at weblink to obtain connection information